Group 1 - The core point of the article is that Wanjia Group's subsidiary, Wuhua Yangke, has received a notice from the Wuhua County Medical Security Management Center regarding violations in prescription management and related regulations [1] - The notice indicates that Wuhua Yangke's blood dialysis center has deviated from standard medical prescription practices, leading to regulatory breaches [1] - As a result of these violations, the Wuhua Medical Security Management Center has implemented measures against Wuhua Yangke [1] Group 2 - As of October 28, 2025, Wanjia Group's stock closed at HKD 0.13, down 4.32%, with a trading volume of 39,600 shares and a turnover of HKD 5,075 [1] - The company has a market capitalization of HKD 77.87 million, ranking 9th in the pharmaceutical commercial sector [1] - Key financial metrics for Wanjia Group include a Return on Equity (ROE) of -37.38%, revenue of HKD 171 million, and a net profit margin of 1.58% [1]
万嘉集团(00401.HK)：五华养可收到五华医保管理中心发出的协议处理告知书